Analysis of the complete open reading frame of genotype 2b hepatitis C virus in association with the response to peginterferon and ribavirin therapy

scientific article

Analysis of the complete open reading frame of genotype 2b hepatitis C virus in association with the response to peginterferon and ribavirin therapy is …
instance of (P31):
scholarly articleQ13442814

External links are
P819ADS bibcode2011PLoSO...624514K
P356DOI10.1371/JOURNAL.PONE.0024514
P932PMC publication ID3174186
P698PubMed publication ID21935415
P5875ResearchGate publication ID51659236

P50authorNaoya SakamotoQ89436415
P2093author name stringTaisuke Inoue
Mamoru Watanabe
Nobuyuki Enomoto
Fumitake Amemiya
Minoru Sakamoto
Shinya Maekawa
Mika Miura
Tomoyoshi Uetake
Mina Nakagawa
Hiroko Shindo
Kazuki Komase
Makoto Kadokura
Ryota Sueki
P2860cites workClinical relevance of hepatitis C virus genotypesQ27469323
Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulationQ27469500
Clinical significance of intrahepatic hepatitis C virus levels in patients with chronic HCV infectionQ27477830
Pretreatment Sequence Diversity Differences in the Full-Length Hepatitis C Virus Open Reading Frame Correlate with Early Response to TherapyQ27481007
Contribution of Genome-Wide HCV Genetic Differences to Outcome of Interferon-Based Therapy in Caucasian American and African American PatientsQ27490885
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trialQ27860949
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearanceQ28255243
Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association studyQ28269827
Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin doseQ29547886
Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis CQ29619541
Diagnosis, management, and treatment of hepatitis C: an updateQ29619682
Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infectionQ29620702
Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trialQ42008293
Sequence variation in hepatitis C virus nonstructural protein 5A predicts clinical outcome of pegylated interferon/ribavirin combination therapyQ42978970
Mutations in the nonstructural 5A gene of European hepatitis C virus isolates and response to interferon alfaQ42981557
Mutations in the interferon sensitivity-determining region of hepatitis C virus genotype 2a correlate with response to pegylated-interferon-alpha 2a monotherapyQ42984548
Mutations in the NS5A gene of hepatitis C virus in North American patients infected with HCV genotype 1a or 1b.Q42985033
Sequence analysis of the NS5A protein of European hepatitis C virus 1b isolates and relation to interferon sensitivity.Q42988613
Association of amino acid substitution pattern in core protein of hepatitis C virus genotype 2a high viral load and virological response to interferon-ribavirin combination therapy.Q42990686
Association of amino acid substitution pattern in core protein of hepatitis C virus genotype 1b high viral load and non-virological response to interferon-ribavirin combination therapy.Q42993815
Mutations in the NS5B region of the hepatitis C virus genome correlate with clinical outcomes of interferon-alpha plus ribavirin combination therapyQ42994454
Mutations in nonstructural protein 5A gene and response to interferon in hepatitis C virus genotype 2 infectionQ42995344
Association of amino acid sequence in the PKR-eIF2 phosphorylation homology domain and response to interferon therapyQ43000728
Pre-treatment prediction of response to pegylated-interferon plus ribavirin for chronic hepatitis C using genetic polymorphism in IL28B and viral factorsQ43031629
Amino acid substitutions in the nonstructural region 5A of hepatitis C virus genotypes 2a and 2b and its relation to viral load and response to interferonQ43037816
Analysis of the complete open reading frame of hepatitis C virus in genotype 2a infection reveals critical sites influencing the response to peginterferon and ribavirin therapyQ45367431
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue9
P407language of work or nameEnglishQ1860
P921main subjectHepatitis C virusQ708693
ribavirinQ421862
P304page(s)e24514
P577publication date2011-09-15
P1433published inPLOS OneQ564954
P1476titleAnalysis of the complete open reading frame of genotype 2b hepatitis C virus in association with the response to peginterferon and ribavirin therapy
P478volume6

Reverse relations

cites work (P2860)
Q33982230HCV genome-wide genetic analyses in context of disease progression and hepatocellular carcinoma
Q38224436Impact of hepatitis C virus heterogeneity on interferon sensitivity: an overview
Q35230421Prediction of hepatitis C virus interferon/ribavirin therapy outcome based on viral nucleotide attributes using machine learning algorithms
Q35826594Production of infectious chimeric hepatitis C virus genotype 2b harboring minimal regions of JFH-1.
Q39157496Response of hepatitis C virus to long-term passage in the presence of alpha interferon: multiple mutations and a common phenotype.
Q37362240Role of viral and host factors in interferon based therapy of hepatitis C virus infection

Search more.